Literature DB >> 32388709

Ghrelin Reduces A-Type Potassium Currents in Dopaminergic Nigral Neurons via the PLC/PKCδ Pathway.

Bao Xue1,2, Chen Li1,2, Xiaoli Chang1,2,3, Hong Jiang1,2, Limin Shi4,5, Junxia Xie6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32388709      PMCID： PMC7410936          DOI： 10.1007/s12264-020-00508-4

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN： 1995-8218            Impact factor:   5.203


× No keyword cloud information.
  15 in total

1.  Protein kinase modulation of dendritic K+ channels in hippocampus involves a mitogen-activated protein kinase pathway.

Authors:  Li-Lian Yuan; J Paige Adams; Michael Swank; J David Sweatt; Daniel Johnston
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

Review 2.  Pathways modulating neural KCNQ/M (Kv7) potassium channels.

Authors:  Patrick Delmas; David A Brown
Journal:  Nat Rev Neurosci       Date:  2005-11       Impact factor: 34.870

Review 3.  Dopamine midbrain neurons in health and Parkinson's disease: emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels.

Authors:  E Dragicevic; J Schiemann; B Liss
Journal:  Neuroscience       Date:  2014-10-30       Impact factor: 3.590

4.  Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels.

Authors:  Limin Shi; Xiling Bian; Zhiqiang Qu; Zegang Ma; Yu Zhou; KeWei Wang; Hong Jiang; Junxia Xie
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

5.  Downregulation of transient K+ channels in dendrites of hippocampal CA1 pyramidal neurons by activation of PKA and PKC.

Authors:  D A Hoffman; D Johnston
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

6.  GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons.

Authors:  F Yang; L Feng; F Zheng; S W Johnson; J Du; L Shen; C P Wu; B Lu
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

Review 7.  The neurological effects of ghrelin in brain diseases: Beyond metabolic functions.

Authors:  Qian Jiao; Xixun Du; Yong Li; Bing Gong; Limin Shi; Tingting Tang; Hong Jiang
Journal:  Neurosci Biobehav Rev       Date:  2016-12-16       Impact factor: 8.989

8.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

9.  Orexins increase the firing activity of nigral dopaminergic neurons and participate in motor control in rats.

Authors:  Cui Liu; Yan Xue; Mei-Fang Liu; Ying Wang; Zi-Ran Liu; Hui-Ling Diao; Lei Chen
Journal:  J Neurochem       Date:  2018-10-15       Impact factor: 5.372

10.  Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model.

Authors:  Hashem Haghdoost-Yazdi; Hossein Piri; Reza Najafipour; Ayda Faraji; Negin Fraidouni; Tahereh Dargahi; Mahmud Alipour Heidari
Journal:  Neurosciences (Riyadh)       Date:  2017-01       Impact factor: 0.906
View more
  1 in total

1.  Ghrelin Represses Thymic Stromal Lymphopoietin Gene Expression through Activation of Glucocorticoid Receptor and Protein Kinase C Delta in Inflamed Skin Keratinocytes.

Authors:  Hayan Jeong; Hyo-Jin Chong; Jangho So; Yejin Jo; Tae-Young Yune; Bong-Gun Ju
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.